Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-10

Clinical Trial Update: Prevention of Contrast-Induced Nephropathy [NA]

View source ↗

Summary

This entry notes the completed clinical trial evaluating prevention of contrast-induced nephropathy sponsored by the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Contrast-induced Nephropathy, Acute Renal Failure | NA | Status: COMPLETED